1. Home
  2. JXN vs BIO Comparison

JXN vs BIO Comparison

Compare JXN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jackson Financial Inc.

JXN

Jackson Financial Inc.

HOLD

Current Price

$107.49

Market Cap

7.2B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$296.43

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JXN
BIO
Founded
1961
1952
Country
United States
United States
Employees
3890
7450
Industry
Life Insurance
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JXN
BIO
Price
$107.49
$296.43
Analyst Decision
Hold
Buy
Analyst Count
5
4
Target Price
$112.40
$339.75
AVG Volume (30 Days)
490.2K
274.0K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
3.43%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.36
$2.59
Revenue Next Year
$3.38
$3.21
P/E Ratio
$16.00
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$69.84
$211.43
52 Week High
$123.61
$343.12

Technical Indicators

Market Signals
Indicator
JXN
BIO
Relative Strength Index (RSI) 52.77 67.10
Support Level $104.99 $293.88
Resistance Level $109.34 $311.09
Average True Range (ATR) 3.04 7.44
MACD 0.50 2.67
Stochastic Oscillator 76.21 96.13

Price Performance

Historical Comparison
JXN
BIO

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: